Efficient and targeted chemo-gene delivery with self-assembled fluoro-nanoparticles for liver fibrosis therapy and recurrence

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

Ratziu, V., Charlotte, F., Heurtier, A., Gombert, S., Giral, P., Bruckert, E., Grimaldi, A., Capron, F., & Poynard, T. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.084 · Cited by 2,106 · see citing works

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: A 5-year open-label follow-up study

Marcellin, P., Gane, E., Buti, M., Afdhal, N., Sievert, W., Jacobson, I. M., Washington, M. K., Germanidis, G., Flaherty, J. F., Schall, R. A., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)61425-1 · Cited by 1,788 · see citing works

Macrophages and Therapeutic Resistance in Cancer

Ruffell, B., & Coussens, L. M. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.02.015 · Cited by 1,474 · see citing works

The burden of liver disease in Europe: A review of available epidemiological data

Blachier, M., Leleu, H., Peck‐Radosavljevic, M., Valla, D. C., & Roudot‐Thoraval, F. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.12.005 · Cited by 1,340 · see citing works

Liver fibrosis and repair: Immune regulation of wound healing in a solid organ

Pellicoro, A., Ramachandran, P., Iredale, J. P., & Fallowfield, J. A. (2014) · Nature Reviews Immunology · doi:10.1038/nri3623 · Cited by 1,310 · see citing works

Advances in polymeric micelles for drug delivery and tumor targeting

Kedar, U., Phutane, P., Shidhaye, S., & Kadam, V. (2010) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.05.005 · Cited by 791 · see citing works

Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice

Pradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613 · see citing works

A fluorinated dendrimer achieves excellent gene transfection efficacy at extremely low nitrogen to phosphorus ratios

Wang, M., Liu, H., Li, L., & Cheng, Y. (2014) · Nature Communications · doi:10.1038/ncomms4053 · Cited by 415 · see citing works

Toxic Reactive Oxygen Species Enhanced Synergistic Combination Therapy by Self‐Assembled Metal‐Phenolic Network Nanoparticles

Dai, Y., Yáng, Z., Cheng, S., Wang, Z., Zhang, R., Zhu, G., Wang, Z., Yung, B. C., Tian, R., Jacobson, O., et al. (2018) · Advanced Materials · doi:10.1002/adma.201704877 · Cited by 411 · see citing works

The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis

Bala, S., Csák, T., Saha, B., Zatsiorsky, J., Kodys, K., Catalano, D. E., Satishchandran, A., & Szabó, G. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.035 · Cited by 305 · see citing works

Targeting Liver Fibrosis

Popov, Y. V., & Schuppan, D. (2009) · Hepatology · doi:10.1002/hep.23123 · Cited by 297 · see citing works

Re-polarization of tumor-associated macrophages to pro-inflammatory M1 macrophages by microRNA-155

Cai, X. F., Yin, Y., Li, N., Zhu, D., Zhang, J., Zhang, C., & Zen, K. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjs044 · Cited by 260 · see citing works

New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis

Wang, Y., Gao, J., Zhang, D., Zhang, J., Ma, J., & Jiang, H. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.02.027 · Cited by 232 · see citing works

Improving Oral Bioavailability of Sorafenib by Optimizing the “Spring” and “Parachute” Based on Molecular Interaction Mechanisms

Liu, C., Chen, Z., Chen, Y., Lu, J. E., Li, Y., Wang, S., Wu, G., & Qian, F. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00837 · Cited by 169 · see citing works

Formulation of Drugs in Block Copolymer Micelles: Drug Loading and Release

Liu, J. J., Lee, H., & Allen, C. J. (2006) · Current Pharmaceutical Design · doi:10.2174/138161206779026263 · Cited by 143 · see citing works

Strategies for improving the payload of small molecular drugs in polymeric micelles

Zhang, Y. X., Ren, T., Gou, J., Zhang, L., Tao, X., Tian, B., Tian, P., Dan-dan, Y., Song, J., Liu, X., et al. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.01.047 · Cited by 126 · see citing works

Exosomal miR‐103‐3p from LPS‐activated THP‐1 macrophage contributes to the activation of hepatic stellate cells

Chen, L., Yao, X., Yao, H., Ji, Q., Ding, G., & Liu, X. (2020) · The FASEB Journal · doi:10.1096/fj.201902307rrr · Cited by 123 · see citing works

Liver fibrosis: Common mechanisms and antifibrotic therapies

Schuppan, D. (2015) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2015.05.005 · Cited by 122 · see citing works

Reprogramming Tumor-Associated Macrophages To Reverse EGFRT790M Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat

Peng, H., Chen, B., Huang, W., Tang, Y., Jiang, Y., Zhang, W., & Huang, Y. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03756 · Cited by 113 · see citing works

Size Switchable Nanoclusters Fueled by Extracellular ATP for Promoting Deep Penetration and MRI‐Guided Tumor Photothermal Therapy

Zhou, Z., Liu, Y., Zhang, M., Li, C., Yang, R., Li, J., Qian, C., & Sun, M. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201904144 · Cited by 112 · see citing works

Inhibition of tumor growth and metastasis by photoimmunotherapy targeting tumor-associated macrophage in a sorafenib-resistant tumor model

Zhang, C., Gao, L., Cai, Y., Liu, H., Gao, D., Lai, J., Jia, B., Wang, F., & Liu, Z. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.027 · Cited by 106 · see citing works

Vitamin A-decorated biocompatible micelles for chemogene therapy of liver fibrosis

Qiao, J.-B., Fan, Q.-Q., Xing, L., Cui, P., He, Y., Zhu, J., Wang, L., Pang, T., Oh, Y., Zhang, C., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.05.032 · Cited by 102 · see citing works

Anti-fibrotic therapy: Lost in translation?

Schuppan, D., & Pinzani, M. (2012) · Journal of Hepatology · doi:10.1016/s0168-8278(12)60008-7 · Cited by 97 · see citing works

Sorafenib in Patients with Hepatocellular Carcinoma—Results of the Observational INSIGHT Study

Ganten, T. M., Stauber, R. E., Schott, E., Malfertheiner, P., Buder, R., Galle, P. R., Göhler, T., Walther, M., Koschny, R., & Gerken, G. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0919 · Cited by 95 · see citing works

Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis

Bhat, M., Tazari, M., & Sebastiani, G. (2017) · PLoS ONE · doi:10.1371/journal.pone.0185192 · Cited by 79 · see citing works

Co-delivery of small molecule hedgehog inhibitor and miRNA for treating liver fibrosis

Kumar, V., Mondal, G., Dutta, R., & Mahato, R. I. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.10.047 · Cited by 77 · see citing works

Sorafenib: A potential therapeutic drug for hepatic fibrosis and its outcomes

Ma, R., Chen, J., Liang, Y., Lin, S., Zhu, L., Liang, X., & Cai, X. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.107 · Cited by 73 · see citing works

Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy

Guo, C., Li, J., Chen, K., Li, S., Feng, J., Liu, T., Wang, F., Zhang, R., Xu, S., Zhou, Y., et al. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s98740 · Cited by 66 · see citing works

The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis

Kurowska‐Stolarska, M., Hasoo, M. K., Welsh, D., Stewart, L., McIntyre, D., Morton, B. E., Johnstone, S. A., Miller, A. M., Asquith, D. L., Millar, N. L., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.09.021 · Cited by 64 · see citing works

Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer

Chen, G., Wang, Y., Wu, P., Zhou, Y., Yu, F., Zhu, C., Li, Z., Yu, H., Wang, K., Li, J., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b01482 · Cited by 59 · see citing works

Isolation and Culture of Primary Murine Hepatic Stellate Cells

Weiskirchen, S., Tag, C. G., Sauer-Lehnen, S., Tacke, F., & Weiskirchen, R. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7113-8_11 · Cited by 59 · see citing works

Combining Fluorination and Bioreducibility for Improved siRNA Polyplex Delivery

Chen, G., Wang, K., Hu, Q., Ding, L., Yu, F., Zhou, Z., Zhou, Y., Li, J., Sun, M., & Oupický, D. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b14184 · Cited by 55 · see citing works

Sorafenib-Loaded Polymeric Micelles As Passive Targeting Therapeutic Agents for Hepatocellular Carcinoma Therapy

Su, Y., Wang, K., Li, Y., Song, W., Xin, Y., Zhao, W., Tian, J., Ren, L., & Lu, L. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0046 · Cited by 53 · see citing works

Dual delivery nanoscale device for miR-345 and gemcitabine co-delivery to treat pancreatic cancer

Uz, M., Kalaga, M., Pothuraju, R., Ju, J., Junker, W. M., Batra, S. K., Mallapragada, S. K., & Rachagani, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.031 · Cited by 51 · see citing works

Enhanced Intracellular Delivery of siRNA by Controlling ATP‐Responsivity of Phenylboronic Acid‐Functionalized Polyion Complex Micelles

Naito, M., Yoshinaga, N., Ishii, T., Matsumoto, A., Miyahara, Y., Miyata, K., & Kataoka, K. (2017) · Macromolecular Bioscience · doi:10.1002/mabi.201700357 · Cited by 50 · see citing works

Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways

Hao, H., Zhang, D., Shi, J., Wang, Y., Chen, L., Guo, Y., Ma, J., Jiang, X., & Jiang, H. (2015) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000316 · Cited by 46 · see citing works

Novel fluorinated polysilsesquioxane hollow spheres: synthesis and application in drug release

Dong, F., Guo, W., Chu, S.-W., & Ha, C. (2010) · Chemical Communications · doi:10.1039/c0cc01658f · Cited by 45 · see citing works

Gene Modulation for Treating Liver Fibrosis

Cheng, K., & Mahato, R. I. (2007) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v24.i2.10 · Cited by 44 · see citing works

Liver X Receptor Inverse Agonist SR9243 Suppresses Nonalcoholic Steatohepatitis Intrahepatic Inflammation and Fibrosis

Huang, P., Kaluba, B., Jiang, X.-L., Chang, S., Tang, X.-F., Mao, L.-F., Zhang, Z.-P., & Huang, F.-Z. (2018) · BioMed Research International · doi:10.1155/2018/8071093 · Cited by 44 · see citing works

Red blood cell-like particles with the ability to avoid lung and spleen accumulation for the treatment of liver fibrosis

Hayashi, K., Yamada, S., Hayashi, H., Sakamoto, W., & Yogo, T. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.11.031 · Cited by 42 · see citing works

Self-assembled fluorodendrimers in the co-delivery of fluorinated drugs and therapeutic genes

Wang, H., Hu, J., Cai, X., Xiao, J., & Cheng, Y. (2016) · Polymer Chemistry · doi:10.1039/c6py00153j · Cited by 40 · see citing works

Effect of Salvianolic-acid B on inhibiting MAPK signaling induced by transforming growth factor-β1 in activated rat hepatic stellate cells

Lv, Z., Song, Y.-F., Xue, D., Zhang, W., Cheng, Y., & Xu, L.-M. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.05.026 · Cited by 39 · see citing works

Tumor necrosis factor-inducible gene 6 reprograms hepatic stellate cells into stem-like cells, which ameliorates liver damage in mouse

Wang, S., Kim, J., Lee, C., Oh, D., Han, J., Kim, T., Kim, S. W., Seo, Y., Oh, S., & Jung, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119375 · Cited by 34 · see citing works

Self-Assembled Polypeptide Nanogels with Enzymatically Transformable Surface as a Small Interfering RNA Delivery Platform

Nishimura, T., Yamada, A., Umezaki, K., Sawada, S., Mukai, S., Sasaki, Y., & Akiyoshi, K. (2017) · Biomacromolecules · doi:10.1021/acs.biomac.7b00937 · Cited by 31 · see citing works

ATP-Charged Nanoclusters Enable Intracellular Protein Delivery and Activity Modulation for Cancer Theranostics

Zhou, Z., Zhang, Q., Yang, R., Wu, H., Zhang, M., Qian, C., Chen, X., & Sun, M. (2020) · iScience · doi:10.1016/j.isci.2020.100872 · Cited by 22 · see citing works

Protective effect of fucoidan from Fucus vesiculosus on liver fibrosis via the TGF-β1/Smad pathway-mediated inhibition of extracellular matrix and autophagy

Li, J., Chen, K., Li, S., Feng, J., Liu, T., Wang, F., Zhang, R., Xu, S., Zhou, Y., Zhou, S., et al. (2016) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 21 · see citing works

High levels of glucose promote the activation of hepatic stellate cells via the p38-mitogen-activated protein kinase signal pathway

Wu, L. K., Liu, Y., Ma, G., Shi, L., & He, X. (2016) · Genetics and Molecular Research · doi:10.4238/gmr.15038419 · Cited by 15 · see citing works

Anti-atherosclerotic effects of LXRα agonist through induced conversion of M1 macrophage to M2.

Dou, F., Chen, J., Cao, H., Jia, Q., Shen, D., Liu, T., & Chen, C. (2019) · PubMed Central · Cited by 13 · see citing works

Current Treatment Guidelines for Chronic Hepatitis B and Their Applications

Uribe, L. A., O’Brien, C., Wong, R. J., Gish, R. G., Tsai, N. C. S., & Nguyen, M. H. (2014) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000130 · Cited by 12 · see citing works

Effect of autophagy‑associated proteins on the arecoline‑induced liver injury in mice

Wang, X., Song, X., Si, Y., Xia, J., Wang, B., & Wang, P. (2018) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2018.6564 · Cited by 9 · see citing works

Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma

Kong, F., Ye, Q., Miao, X., Liu, X., Huang, S., Xiong, L., Wen, Y., & Zhang, Z. (2021) · Theranostics · doi:10.7150/thno.54822 · Cited by 221 · see citing works

Fluorination Promotes the Cytosolic Delivery of Genes, Proteins, and Peptides

Lv, J., Wang, H., Rong, G., & Cheng, Y. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.1c00766 · Cited by 157 · see citing works

Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems

Liu, J., Liu, J., Mu, W., Ma, Q., Zhai, X., Jin, B., Liu, Y., & Zhang, N. (2024) · ACS Nano · doi:10.1021/acsnano.4c02380 · Cited by 74 · see citing works

Manipulating Offense and Defense Signaling to Fight Cold Tumors with Carrier‐Free Nanoassembly of Fluorinated Prodrug and siRNA

Wu, P., Zhang, H., Sun, M., Mao, S., He, Q., Shi, Y., Deng, Y., Dong, Z., Xu, Q., Zhao, C., et al. (2022) · Advanced Materials · doi:10.1002/adma.202203019 · Cited by 55 · see citing works

Engineered EGCG‐Containing Biomimetic Nanoassemblies as Effective Delivery Platform for Enhanced Cancer Therapy

Wu, P., Zhang, H., Yin, Y., Sun, M., Mao, S., Chen, H., Deng, Y., Chen, S., Li, S., & Sun, B. (2022) · Advanced Science · doi:10.1002/advs.202105894 · Cited by 50 · see citing works

Remodeling of the liver fibrosis microenvironment based on nilotinib-loaded multicatalytic nanozymes with boosted antifibrogenic activity

Jing, H., Ren, Y., Zhou, Y., Xu, M., Křížková, S., Heger, Z., Lü, Q., Wang, S., Liang, X., Adam, V., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.020 · Cited by 40 · see citing works

An Autologous Macrophage‐Based Phenotypic Transformation‐Collagen Degradation System Treating Advanced Liver Fibrosis

Duan, B., Liu, Y., Li, X., Han, M., Yu, H., Hong, H., Zhang, L., Xing, L., & Jiang, H. (2024) · Advanced Science · doi:10.1002/advs.202306899 · Cited by 38 · see citing works

Hepatic Stellate Cell- and Liver Microbiome-Specific Delivery System for Dihydrotanshinone I to Ameliorate Liver Fibrosis

Niu, X., Meng, Y., Cui, J., Li, R., Ding, X. Q., Niu, B., Chang, G., Xu, N., Li, G., Wang, Y., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c06626 · Cited by 38 · see citing works

Liver fibrosis: pathological features, clinical treatment and application of therapeutic nanoagents

Chen, L., Guo, W., Mao, C., Shen, J., & Wan, M. (2024) · Journal of Materials Chemistry B · doi:10.1039/d3tb02790b · Cited by 33 · see citing works

Mannose-decorated ginsenoside Rb1 albumin nanoparticles for targeted anti-inflammatory therapy

Fu, Z., Wang, X.-H., Lu, X., Yang, Y., Zhao, L., Zhou, L., Wang, K., & Fu, H. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.962380 · Cited by 25 · see citing works

Synergetic regulation of kupffer cells, extracellular matrix and hepatic stellate cells with versatile CXCR4-inhibiting nanocomplex for magnified therapy in liver fibrosis

Wu, P., Luo, X., Sun, M., Sun, B., & Sun, M. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121492 · Cited by 25 · see citing works

Lysosome-Targeting Nanochimeras Attenuating Liver Fibrosis by Interconnected Transforming Growth Factor-β Reduction and Activin Receptor-Like Kinase 5 Degradation.

Liu, H., Qi, Y.-Q., Wang, L., Zhang, Y., Chen, H.-Q., Zhao, Y., Min, H., Nie, G.-J., & Liang, H. (2025) · ACS Nano · doi:10.1021/acsnano.5c00985 · Cited by 23 · see citing works

Long-Term Release of Dexamethasone With a Polycaprolactone-Coated Electrode Alleviates Fibrosis in Cochlear Implantation

Chen, D., Luo, Y., Pan, J., Chen, A., Ma, D., Xu, M., Tang, J., & Zhang, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.740576 · Cited by 22 · see citing works

Reversal of hepatic fibrosis by the co-delivery of drug and ribonucleoprotein-based genome editor

Gu, J., Sun, J., Tian, K. V., Bian, J., Peng, J., Xu, S. Q., & Zhao, L. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122133 · Cited by 19 · see citing works

Vitamin A - modified Betulin polymer micelles with hepatic targeting capability for hepatic fibrosis protection

Liu, X., Li, D., Li, T. Y., Wu, Y., Piao, J. S., & Piao, M. G. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106189 · Cited by 18 · see citing works

Construction of GSH-triggered cationic fluoropolymers as two-in-one nanoplatforms for combined chemo-gene therapy

Zhan, Y.-R., Tan, J., Hei, M.-W., Zhang, S., Zhang, J., & Yu, X. (2022) · Journal of Materials Chemistry B · doi:10.1039/d1tb02602j · Cited by 17 · see citing works

Fluorinated vectors for gene delivery

Wan, Y., Yang, Y., Wu, M., & Feng, S. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2022.2131769 · Cited by 17 · see citing works

Kupffer cell-targeting strategy for the protection of hepatic ischemia/reperfusion injury

Dai, Q., Jiang, W., Liu, H., Qing, X., Wang, G., Huang, F., Yang, Z., Wang, C., Gu, E., Zhao, H., et al. (2021) · Nanotechnology · doi:10.1088/1361-6528/abde02 · Cited by 14 · see citing works

Poly-antioxidants for enhanced anti-miR-155 delivery and synergistic therapy of metastatic breast cancer

Zhang, Q., Huang, Y., Yang, R., Mu, J., Zhou, Z., & Sun, M. (2022) · Biomaterials Science · doi:10.1039/d1bm02022f · Cited by 14 · see citing works

Targeting Metabolism: Innovative Therapies for MASLD Unveiled

Wang, W., Gao, X., Niu, W., Yin, J., & He, K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094077 · Cited by 14 · see citing works

A boronate-based modular assembly nanosystem to block the undesirable crosstalk between hepatic stellate cells and Kupffer cells

Jia, H., Ding, L., Yu, A., Tang, W., Tang, S., Zhang, C., & Oupický, D. (2023) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.07.018 · Cited by 12 · see citing works

Microfluidics-enabled fluorinated assembly of EGCG-ligands-siTOX nanoparticles for synergetic tumor cells and exhausted t cells regulation in cancer immunotherapy

Han, X., Zhang, G., Wu, X., Xu, S., Liu, J., Wang, K., Liu, T., & Wu, P. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02328-4 · Cited by 12 · see citing works

Advances in nanotechnology for the diagnosis and management of metabolic dysfunction-associated steatotic liver disease

Li, F., Yuan, R., Zhang, J., Su, B., & Qi, X. (2025) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2025.101025 · Cited by 12 · see citing works

Fluorinated Cell-Penetrating Peptide for Co-Delivering siHIF-1α and Sorafenib to Enhance In Vitro Anti-Tumor Efficacy

Wan, Y., Yang, Y., Lai, Q., Wang, W., Wu, M., & Feng, S. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122789 · Cited by 11 · see citing works

Crosstalk between Hepatic Stellate Cells and Hepatic Macrophages in Metabolic Dysfunction–Associated Steatohepatitis

Zhong, H., Liu, C., Huang, Z., Tan, P., Chen, H., & Fu, W. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.02.003 · Cited by 9 · see citing works

Advanced strategies based on nanomedicine for Liver fibrosis treatment

Zhang, L., Liu, T., Shen, H., Liu, B.-H., Mei, Y., Liu, Y., Chen, S., Ma, X., He, C., Hu, T., et al. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126437 · Cited by 7 · see citing works

Synergetic regulation of cancer cells and exhausted T cells to fight cold tumors with a fluorinated EGCG-based nanocomplex

Zhang, J., Wang, M., He, D., Zhang, L. N., Liu, T., & Wang, K. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02205-6 · Cited by 5 · see citing works

Pure drug nanomedicines - where we are?

Lai, Y., Xie, B., Zhang, W., & He, W. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60851-x · Cited by 3 · see citing works

Targeting the Hepatic Stellate Cell Microenvironment: Nanomedicine Strategies for Liver Fibrosis Therapy

Pei, L., Du, X., Mao, Z., Ding, K., Li, J., Liu, T., & Zhao, Y. (2025) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5c01439 · Cited by 3 · see citing works

Genetically Engineered Membrane‐Coated Nanoparticles as Versatile Platforms with Reduced Protein Corona for Targeted siRNA Delivery

Zhang, P., Zhao, L., Liu, H., Chen, H., Wu, Y., Wang, X., Liu, G., & Zeng, Y. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300228 · Cited by 2 · see citing works

Nanoparticles for Creating a Strategy to Stimulate Liver Regeneration

Rodimova, S. A., Kozlov, D., Krylov, D. P., Mikhailova, L. V., Kozlova, V., Gavrina, A. I., Mozherov, A. M., Elagin, V. V., & Kuznetsova, D. S. (2024) · Современные технологии в медицине · doi:10.17691/stm2024.16.3.04 · Cited by 1 · see citing works

Engineered virus-derived platform enables glutathione depletion and cuproptosis for enhanced cancer immunotherapy

Wu, P., Wu, X., Li, M., Yan, X., Zhou, M., Zhang, G., Yan, X., Liu, T., Zhu, X., & Han, X. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114619 · Cited by 1 · see citing works

Additional file 1 of Synergetic regulation of cancer cells and exhausted T cells to fight cold tumors with a fluorinated EGCG-based nanocomplex

Zhang, J., Wang, M., He, D., Zhang, L., Liu, T., & Wang, K. (2023) · Figshare · doi:10.6084/m9.figshare.24558177

Additional file 1 of Microfluidics-enabled fluorinated assembly of EGCG-ligands-siTOX nanoparticles for synergetic tumor cells and exhausted t cells regulation in cancer immunotherapy

Han, X., Zhang, G., Wu, X., Xu, S., Liu, J., Wang, K., Liu, T., & Wu, P. (2024) · Figshare · doi:10.6084/m9.figshare.26688287

Nanocomposites to Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Therapy

Liu, J., Zhou, S., Wei, Y., Du, J., Jia, F., Dong, W., Cao, Y., Shi, Z., Mu, H., Chen, L., et al. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s535455

Adult-Onset Diabetes and Liver Fibrosis as Diagnostic Clues to Alström Syndrome: A Case Report

Balogun, F. O., Honarius, S., Yeoh, M. L. Y., Abouibrahim, M., Sayed, M., & Randall, J. (2026) · Cureus · doi:10.7759/cureus.102959

Multifunctional nucleic acid-based therapy in fibrosis-related diseases

Cheng, J., Zhou, M., Guo, Y., Yang, Y., Lv, W., Renzeng, Y. A. N. G., Xie, Y., Jiang, Y., Yao, L., Qi, C., et al. (2026) · Science China Chemistry · doi:10.1007/s11426-025-3231-6

Hepatic stellate cell-targeted chemo-gene therapy for liver fibrosis using fluorinated peptide-lipid hybrid nanoparticles

Lai, Q., Li, W., Hu, D., Huang, Z., Wu, M., Feng, S., & Wan, Y. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.10.044 · Cited by 34 · see citing works

Co-delivery of pirfenidone and siRNA in ZIF-based nanoparticles for dual inhibition of hepatic stellate cell activation in liver fibrotic therapy

Wang, K., Chen, H. H., Qin, S., Chen, S., Zhang, Q. Y., Chen, J., Di, D., Su, G., & Yuan, Y. (2023) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2023.113567 · Cited by 17 · see citing works

“Kupffer Cell Teleportation” Strategy for Liver Fibrosis Alleviation Based on Hybrid Polymer‐ Bimetallic Sequential Delivery System

Qiu, Z., Milichko, V. A., Zhou, Y., Jing, H., Lü, Q., Wang, H., Kang, B., Wang, X., & Li, N. (2023) · Advanced Functional Materials · doi:10.1002/adfm.202309690 · Cited by 12 · see citing works

Dual-responsive and CD44-targeted nanotherapy to remodel the fibrotic niche for reversing liver fibrosis

Li, J.-W., Chen, J., Wang, L., Zhao, W., Xia, Y., Zhang, J.-H., Zhou, J., Song, H., Ji, X., Zhang, Z.-J., et al. (2026) · Chemical Engineering Journal · doi:10.1016/j.cej.2026.179835 · Cited by 1 · see citing works

Synergistic MicroRNA Therapy in Liver Fibrotic Rat Using MRI‐Visible Nanocarrier Targeting Hepatic Stellate Cells

Wu, J. H., Huang, J., Kuang, S., Chen, J., Li, M., Chen, B., Wang, J., Cheng, D., & Shuai, X. (2019) · Advanced Science · doi:10.1002/advs.201801809 · Cited by 89 · see citing works